Busulfan Clearance Model for Pediatric Patients Undergoing Transplantation
Researchers sought to develop a model for busulfan dosing in pediatric patients receiving HSCT.
General Oncology
Cell-Free DNA Blood Test Shows Promise as Assessment to Screen for Lung Cancer
Researchers sought to determine whether peripheral blood tests of cfDNA would be a noninvasive option for lung cancer detection.
Tool May Predict Risk of Subsequent Malignancies in Childhood Cancer Survivors
The tool proved most effective in survivors of solid tumors or central nervous system tumors and in patients not exposed to radiation during treatment of their primary malignancy.
Inflammatory Biomarkers Help Predict Toxicity With CAR-T Cell Therapy
Researchers sought to determine whether measures of inflammation would be associated with immune-related toxicities after CAR-T therapy.
Concurrent Use of Cannabis May Reduce Efficacy of Immune Checkpoint Inhibitors
Observations suggest that concurrent use of cannabis with immune checkpoint inhibitors should be discouraged until more information is available.
Recommendations for Nurse Management of Immunotherapy-Induced Cytokine Release Syndrome in Pediatric Patients
A systematic review identified nursing tips for the care of pediatric patients at risk of cytokine release syndrome after blinatumomab or CAR-T therapy.
Nomogram May Help Predict Deep Vein Thrombosis After Liver Surgery for Patients With Hepatocellular Carcinoma
Researchers sought to determine whether a nomogram may be helpful to predict risk of DVT after laparoscopic hepatectomy in patients with HCC.
Effectiveness of Corticosteroids in the Treatment of Chemotherapy-Induced Thrombocytopenia
Researchers sought to determine whether corticosteroids would be an effective treatment for patients with chemotherapy-induced thrombocytopenia.
COVID-19: What Do We Know About Outcomes in Hematologic Malignancies?
Patients with hematologic malignancies are at an advanced risk when they also have COVID-19. What have some recent studies suggested about outcomes in patients who have both?
Patients With Cancer and COVID-19 Face Increased Risk of Thromboembolic Events
Researchers sought to determine whether patients with cancer who had COVID-19 had an increased risk of experiencing thromboembolic events.
- Loading...
Loading...
Next post in ESMO 2021
Loading... 
Loading...